Showing results (101-110 of 135) with videos related to
Sort By:
Pageof 14
JCI Insight|August 18, 2017
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversalGuoxin Wu, Michael Swanson, Aarthi Talla, et al.AIDS (London, England)|April 2, 2019
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individualsLine K Vibholm, Christina V Konrad, Mariane H Schleimann, et al.Journal of Virology|May 26, 2017
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment InterruptionWen Shi Lee, Anne B Kristensen, Thomas A Rasmussen, et al.Vaccine|December 24, 2025
Immunogenicity of SARS-CoV-2 primary vaccination and boosters in patients with immune-mediated inflammatory diseases: Impact of immunosuppressive therapyFredrikke Dam Larsen, Anna Karina Juhl, Lisa Loksø Dietz, et al.Journal of Virology|February 1, 2019
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment InterruptionLine K Vibholm, Julio C C Lorenzi, Joy A Pai, et al.Plos Pathogens|September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S Søgaard, Mette E Graversen, Steffen Leth, et al.Scientific Reports|June 25, 2024
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicityAnna R Mahr, Maia M C Bennett-Boehm, Frederik H Rothemejer, et al.Ebiomedicine|February 2, 2021
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responsesLine K Vibholm, Stine S F Nielsen, Marie H Pahus, et al.Plos One|September 20, 2023
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell clusterStine Sofie Frank Lende, Nanna Møller Barnkob, Randi Westh Hansen, et al.Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.Pageof 14